Muscular Diseases

Non-invasive BCI-controlled Assistive Devices

Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping

Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients

Mollii Suit and Fibromyalgia (EXOFIB 2)

A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia

Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia

A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia

Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers

Virtual Path Planning for Image-guided Needle Interventions

Diagnoses Associated With Persistent Elevation of Creatine Kinase

Ultrasound Grayscale Analysis in ARDS covid19

Study of Pioglitazone in Sporadic Inclusion Body Myositis

New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy

An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy

Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

Non-invasive Molecular Imaging of Muscle Structure (MSOT_muscles)